U.S. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers, 2019

This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Competitive Assessments

- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- Decode Genetics
- Diadexus
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Grifols
- Hologic
- Illumina
- LabCorp
- Leica Biosystems
- Li-Cor Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- PerkinElmer
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens Healthineers
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher

List of Tables

US Molecular Diagnostics Market by Major Supplier
US HIV/Hepatitis C NAT Market Reagent Sales By Major Supplier
US West Nile Virus NAT Market Reagent Sales By Major Supplier


Competitive Profiles
- Abbott
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- CellMark Forensics/LabCorp
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech/Leica
- Li-Cor Biosciences
- Monogram Biosciences/LabCorp
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher/Affymetrix

List Of Tables


US Molecular Diagnostics Market
by Major Supplier
US HIV/Hepatitis C NAT Market
Reagent Sales by Major Supplier
US West Nile Virus NAT Market
Reagent Sales by Major Supplier

2020 U.S. POC Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers--Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends

This new 418-page report contains 42 tables, and provides a comprehensive analysis of the POC coagulation testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and

USD 5500 View Report

2020 U.S. POC Clinical Chemistry and Immunodiagnostics Forecasts for 100 Tests: Supplier Shares and Strategies, Instrumentation Review, Emerging technologies--Physician Offices, ER, OR, ICU, Cancer Clinics, Ambulatory Care, Surgery and Birth Centers, Nursing Homes

This new 373-page report contains 61 tables, and provides a comprehensive analysis of the POC clinical chemistry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and

USD 4500 View Report

2020 Winning Strategies in Molecular Diagnostics: US, Europe, Japan--Integrating New Technology Planning with Business Strategies--Country Shares and Market Segment Forecasts for 100 Tests--Technological Breakthroughs, Emerging Tests, Competitive Intelligence

This new seven-country study contains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular

USD 24500 View Report

2020 Molecular Diagnostics Market: Supplier Shares, Sales Forecasts and Facilities by Country

This report provides:- Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA.- Estimates of facilities performing DNA sequencing and molecular diagnostic testing by

USD 3500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available